Blood Preparation Market - Pmr Market Insight Report 2015 to 2021

Blood Preparation Market - PMR Market Insight Report 2015 to 2021

Persistence Market Research

Blood Preparation Market - PMR Market

Insight Report 2015 to 2021

Persistence Market Research

1

Blood Preparation Market - PMR Market Insight Report 2015 to 2021

Persistence Market Research Released New Market Report on “Blood Preparation

Market - PMR Market Insight Report 2015 to 2021”.

Blood is a mixture of various component including Red Blood Cells (RBC), White

Blood Cells (WBC), plasma, and platelets that circulate continuously inside the body

to provide nutrition, and oxygen to body, and removes waste from the body. The

average person has about 5 liters of blood and plasma that makes up about half of

the content of the blood. Many people need transfusion in various conditions such

as operations, a severe infection or liver diseases which stops body from making

blood, and bleeding disorders such as hemophilia or thrombocytopenia. According

to World Health Organization (WHO), 108 million blood donation collected globally in

2014 which was an increase of 8.6 million voluntary blood donation from 2004 to

2012. Previously, whole blood was the only preparation used to replace RBC,

platelets, or coagulation factors. However, now a day’s whole blood is separated

into various blood components and further derivatives can be obtained from plasma

by fractionation procedure. Hence, one unit of blood can be useful for more than

one patient.

Buy Full Report: http://www.persistencemarketresearch.com/marketresearch/blood-preparation-market.asp

The global blood preparation market is segmented by product type, and by blood

thinning agents. By product type market is segmented into whole blood, blood

components, and blood derivatives and the blood thinning agents further

segmented into platelet aggregation inhibitor, fibrinolytics, and anticoagulants.

Platelet aggregate inhibitors include glycoprotein Inhibitors, ADP Antagonists, COX

Inhibitors, and Phosphodiesterase Inhibitors....